| [1] |
魏葆珺，韩晓红. 外周血循环肿瘤细胞的检测及其临床意义 [J]. 中华检验医学杂志, 2012, 35(11):1053-1056.
|
| [2] |
Breitbach S, Tug S, Simon P. Circulating cell-free DNA: an up-coming molecular marker in exercise physiology [J]. Sports Med, 2012, 42(7):565-586.
|
| [3] |
Sausen M, Parpart S, Diaz LA Jr. Circulating tumor DNA moves further into the spotlight [J]. Genome Med, 2014, 6(5):35.
|
| [4] |
Nagata S, Hanayama R, Kawane K.Autoimmunityand the clearance of dead cells [J]. Cell, 2010, 140(5):619-630.
|
| [5] |
Diaz LA Jr, Bardelli A. Liquid biopsies: genotyping circulating tumor DNA [J]. J Clin Oncol, 2014, 32(6):579-586.
|
| [6] |
Hou JM, Krebs M, Ward T, et al. Circulating tumor cells as a window on metastasis biology in lung cancer [J]. Am J Pathol, 2011, 178(3):989-996.
|
| [7] |
Bonnomet A, Brysse A, Tachsidis A, et al. Epithelial-to-mesenchy-mal transitions and circulating rumor cells [J]. J Manunary Gland Biol Neoplasia, 2010, 15(2):261-273.
|
| [8] |
Driemel C, Kremling H, Schumacher S, et al. Context-dependent adaption of EpCAM expression in early systemic esophageal cancer [J]. Oncogene, 2014, 33(41):4904-4915.
|
| [9] |
Marrinucci D, Bethel K, Bruce RH, et al. Case study of the morphologic variation of circulating tumor cells [J]. Hum Pathol, 2007, 38(3):514-519.
|
| [10] |
Hou JM, Krebs MG, Lee L, et al. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer [J]. Clin Oncol, 2012, 30(5):525-532.
|
| [11] |
Ha M, Kim VN. Regulation of microRNA biogenesis [J]. Nat Rev Mol Cell Biol, 2014, 15(8):509-524.
|
| [12] |
Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and downregulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia [J]. Proc Natl Acad Sci, 2002, 99(24):15524-15529.
|
| [13] |
Guz M, Rivero-Muller A, Okon E, et al. MicroRNAs-role in lung cancer [J]. Dis Markers, 2014, 2014:218169.
|
| [14] |
Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers [J]. Nature, 2005, 435(7043):834-838.
|
| [15] |
Gilad S, Meiri E, Yogev Y, et al. Serum microRNAs are promising novel biomarkers [J]. PLoS One, 2008, 3(9):e3148.
|
| [16] |
Jahr S. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells [J]. Cancer Res, 2001, 61(4):1659-1665.
|
| [17] |
Grutzmann R, Molnar B, Pilarsky C, et al. Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay [J]. PLoS One, 2008, 3(11):e3759.
|
| [18] |
Warren JD, Xiong W, Bunker AM, et al. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer [J]. BMC Med, 2011, 9(24):133.
|
| [19] |
Allegra CJ. American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy [J]. J Clin Oncol, 2009, 27(12):2091-2096.
|
| [20] |
Nik-Zainal S, Van Loo P, Wedge DC, et al. The life history of 21 breast cancers [J]. Cell , 2012, 149(5):994-1007.
|
| [21] |
Franchina T, Amodeo V, Bronte G, et al. Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non-small cell lung cancer [J]. J Cell Physiol, 2014, 229(1):97-99.
|
| [22] |
Amodeo V, Bazan V, Fanale D, et al. Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense? [J]. Expert Opin Ther Targets, 2013, 17(11):1249-1261.
|
| [23] |
Bronte F, BronteG, FanaleD, et al. HepatomiRNoma: the proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma [J]. Crit Rev Oncol Hematol, 2016, 97:312-321.
|
| [24] |
Aktas B, Tewes M. Fehm T, et al. Stem cell and epithelial-mesenchymaltransition markers are frequently overexpressed in circulating tumor cell of metastatic breast cancer patients [J]. Breast Cancer Res, 2009, 11(4):R46.
|
| [25] |
Papadaki MA, Kallergi G, Zafeiriou Z, et al. Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer [J]. BMC Cancer, 2014, 14:651.
|
| [26] |
Petriella D, Galetta D, Rubini V, et al. Molecular profiling of thin-prep FNA samples in assisting clinical management of nonesmall-cell lung cancer [J]. Mol Biotechnol, 2013, 54(3):913-919.
|
| [27] |
Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis [J]. Cancer Cell, 2006, 9(3):189-198.
|
| [28] |
Huang W, Hu J, Yang DW, et al. Two microRNA panels to discriminate three subtypes of lung carcinoma in bronchial brushing specimens [J]. Am J Respir Crit Care Med, 2012, 186(11):1160-1167.
|
| [29] |
Lebanony D, Benjamin H, Gilad S, et al. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous nonesmall-cell lung carcinoma [J]. J Clin Oncol, 2009, 27(12):2030-2037.
|
| [30] |
Xie Y, Todd NW, Liu Z, et al. Altered miRNA expression in sputum for diagnosis of nonesmall-cell lung cancer [J]. Lung Cancer, 2010, 67(2):170-176.
|
| [31] |
Shen J, Liao J, Guarnera MA, et al. Analysis of MicroRNAs in sputum to improve computed tomography for lung cancer diagnosis [J]. J Thorac Oncol, 2014, 9(1):33-40.
|
| [32] |
Shen J, Todd NW, Zhang H, et al. Plasma microRNAs as potential biomarkers for nonesmall-cell lung cancer [J]. Lab Invest, 2011, 91(4):579-587.
|
| [33] |
Leidinger P, Keller A, Backes C, et al. MicroRNA expression changes after lung cancer resection: a follow-up study [J]. RNA Biol, 2012, 9(6):900-910.
|
| [34] |
Kossenkov AV, Vachani A, Chang C, et al. Resection of nonesmall-cell lung cancers reverses tumor-induced gene expression changes in the peripheral immune system [J]. Clin Cancer Res, 2011, 17(18):5867-5877.
|
| [35] |
Le HB, Zhu WY, Chen DD, et al. Evaluation of dynamic change of serum miR- 21 and miR-24 in pre- and post-operative lung carcinoma patients [J]. Med Oncol, 2012, 29(5):3190-3197.
|
| [36] |
Aushev VN, Zborovskaya IB, Laktionov KK, et al. Comparisons of microRNA patterns in plasma before and after tumor removal reveal new biomarkers of lung squamous cell carcinoma [J]. PLoS One, 2013, 8(10):e78649.
|
| [37] |
Normanno N, Rossi A, Morabito A, et al.Prognostic value of circulating tumor cells′ reduction in patients with extensive small cell lung cancer [J]. Lung cancer, 2014, 85(2):314-319.
|
| [38] |
Vona G, Sabile A, Louha M, et al.Isolation by size of epithelial tumor cells:a new method for the immunomorphological and moleader charauteri-zation of ciralating tumor cells [J]. The American Jewnal of Pathiogy, 2000, 156(1):57-63.
|